(2011). The Illusion of Interchangeability: The Benefits and Dangers of Guidance-Plus Rulemaking in the FDA's Biosimilar Approval Process. Administrative Law Review.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"The Illusion of Interchangeability: The Benefits and Dangers of Guidance-Plus Rulemaking in the FDA's Biosimilar Approval Process."
Administrative Law Review 2011.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"The Illusion of Interchangeability: The Benefits and Dangers of Guidance-Plus Rulemaking in the FDA's Biosimilar Approval Process."
Administrative Law Review, 2011.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.